In tobacco studies, biomarkers to assess exposure to tobacco products and biomarkers of potential harm are both of interest. These biomarkers are used to characterize exposure to constituents present in tobacco products (such as HPHCs) and to determine the potential health impact from use of these products.
Biomarkers of exposure may be the constituents or their metabolites.
- Biomarkers of Exposure
- Biomarkers of Potential Harm
- Functional Endpoint biomarkers (cardiac function)
24 hour urine collected by sponsor (volume represented here)→ Urine aliquots sent to lab→ testing done→ results sent to sponsor (units of conc)→ sponsor converts to units/24hr
results normalized to creatinine
Overview
Content Tools